Fig. 3From: Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer modelTumor to blood and tumor to muscle activity concentration ratios for individual agentsBack to article page